Genetic engineering of a Ca2+ dependent chemical switch into the linear biomotor kinesin  by Konishi, Kaoru et al.
FEBS Letters 580 (2006) 3589–3594Genetic engineering of a Ca2+ dependent chemical switch into the linear
biomotor kinesin
Kaoru Konishia, Taro Q.P. Uyedab,*, Tai Kuboa,*
a National Institute of Advanced Industrial Science and Technology (AIST), Neuroscience Research Institute, AIST Tsukuba Central 6,
1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan
b National Institute of Advanced Industrial Science and Technology (AIST), Gene Function Research Center, AIST Tsukuba Central 4,
1-1-1 Higashi, Tsukuba, Ibaraki 305-8562, Japan
Received 23 March 2006; revised 12 May 2006; accepted 16 May 2006
Available online 24 May 2006
Edited by Judit Ova´diAbstract Kinesin is a linear motor protein driven by energy re-
leased by ATP hydrolysis. In the present work, we genetically in-
stalled an M13 peptide sequence into Loop 12 of kinesin, which
is one of the major microtubule binding regions of the protein.
Because the M13 sequence has high aﬃnity for Ca2+-calmodulin,
the association of the engineered kinesin with microtubules
showed a steep Ca2+-dependency in ATPase activity at Ca2+
concentrations of pCa 6.5–8. The calmodulin-binding domain
of plant kinesin-like calmodulin-binding protein is also known
to confer Ca2+-calmodulin regulation to kinesins. Unlike this
plant kinesin, however, our novel engineered kinesin achieves this
regulation while maintaining the interaction between kinesin and
microtubules. The engineered kinesin is switched on/oﬀ reversibly
by an external signal (i.e., Ca2+-calmodulin) and, thus, can be
used as a model system for a bio/nano-actuator.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Eukaryotic cells harness numerous types of biomolecular
motors [1,2]. For example, myosin, kinesin, and RNA poly-
merase act as linear motors and move along actin ﬁlaments,
microtubules, and DNA, respectively. The F1Fo-ATPase func-
tions as a rotary motor involved in adenosine triphosphate
(ATP) synthesis, using H+ gradients across the membrane as
the energy source. A number of investigators have attempted
to create nanoactuators from biomolecular motors [3–10],
but wild-type proteins are not necessarily optimized for use
as nanoactuators under artiﬁcial conditions. To create novel
nanoactuators by combining electronic devices and biomolec-
ular motors, an externally controllable switch is necessary toAbbreviations: EGTA, O,O0-bis(2-aminoethyl)ethyleneglycol-N,N,N0,
N0-tetra acetic acid; ATP, adenosine triphosphate; SDS, sodium
dodecyl sulfate; DTT, dithiothreitol; PDB, protein data bank
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doi:10.1016/j.febslet.2006.05.037regulate biomolecular motor activity. Liu et al. [11] success-
fully designed and installed a chemical switch activated by zinc
ions in the F1-ATPase. In linear biomolecular motors, how-
ever, integration of an artiﬁcial switch has not been reported.
Kinesins are a large family of biomotors that move along
microtubules using energy released by ATP hydrolysis. Con-
ventional kinesin, the founding member of the family, was ini-
tially isolated from neurons as a motor which transported
intracellular vesicles along microtubules in axons. Kinesin is
a dimeric protein, and moves along microtubules processively
through the coordinated action of two motor domains in the
dimer. Microtubules are cylindrical polymers of a/b tubulin
heterodimers with a diameter of 25 nm and can be many
micrometers in length. Wild-type human conventional kinesin
is regulated by binding of cargo vesicles to the carboxyl tail do-
main [12,13], but, is not known to be regulated by other en-
zymes or solutes such as metal ions. Furthermore,
conventional kinesin adsorbed onto solid substrates, such as
glass surfaces or plastic beads, is no longer regulated by inter-
actions with cargo vesicles [13]. Therefore, we engineered a me-
tal ion-sensitive switch into human conventional kinesin to
facilitate the control of the protein by an external signal. We
used the Ca2+-dependent binding of calmodulin to the M13
peptide [14], the calmodulin binding region of rabbit skeletal
muscle myosin light chain kinase. In the presence of micromo-
lar concentrations of Ca2+, calmodulin binds 4 Ca2+ ions. The
Ca2+-calmodulin complex binds the M13 peptide with high
aﬃnity. This binding is reversible, so that chelating Ca2+ in-
duces dissociation of calmodulin from the M13 peptide. A
Ca2+-calmodulin-binding domain (CBD) with similar function
has been identiﬁed in a plant kinesin-like calmodulin-binding
protein (KCBP) [15]. The CBD, when fused to a conventional
kinesin, made the ATPase activity of kinesin and its dissocia-
tion from microtubules Ca2+-calmodulin sensitive [16]. We
introduced the M13 peptide sequence into Loop 12 of kinesin.
The engineered kinesin showed an all or none type of reversible
regulation by Ca2+ and calmodulin without substantially
aﬀecting the interaction between kinesin and the microtubule.2. Materials and methods
2.1. Motor proteins
The human kinesin heavy chain gene truncated at amino acid resi-
due 560 was fused with a C-terminal His tag in the pET17b vector
(Novagen) to generate a conventional kinesin construct (K560). Engi-
neered kinesin cDNAs were constructed by inserting the M13 peptideblished by Elsevier B.V. All rights reserved.
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of kinesin, as follows. A BamHI site was generated between the
Thr273 and Tyr274 in Loop 12 by site-directed mutagenesis. The M13
peptide sequence was cloned by PCR using two linker primers (F-lin-
ker primer 5 0-TGGGATCCAAAAGAAGATGG-30; R-linker primer,
5 0-ACGGATCCTAATGCACCTGATG-30; BamHI sites underlined).
The resultant cDNA was digested with BamHI, and inserted in the
modiﬁed K560 gene at the engineered restriction site. Consequently,
the inserted M13 peptide contains Gly-Ser as a linker at both junc-
tions. Both wild-type and mutant kinesin proteins were expressed in
E. coli BL21 (DE3) + pT-Trx [17], and puriﬁed using a Ni-NTA aga-
rose (QIAGEN) column. Tubulin was puriﬁed from porcine brain
according to the procedure of Hiratsuka et al. [18].
2.2. Gliding assay
Gliding assays were performed using rhodamine-labeled micro-
tubules, following standard protocols [18], but with diﬀerent assay
buﬀers. We employed two buﬀers, speciﬁcally, one containing O,O 0-
bis(2-aminoethyl)ethyleneglycol-N,N,N 0,N 0-tetra acetic acid (EGTA)
(20 mM Tris–acetate, pH 7.5, 10 mM potassium acetate, 5 mM EGTA,
8 mM MgSO4, 20 mM glucose, 0.5 mg/ml casein, 20 lg/ml catalase,
0.1 mg/ml glucose oxidase, 1 mM ATP, 0.5% b-mercaptoethanol,
40 lM taxol) and the other containing Ca2+-calmodulin (the same buf-
fer containing 0.1 mM CaCl2 and 0.2 mg/ml calmodulin (SIGMA)
instead of EGTA). Assays were performed at 30 C.
2.3. ATPase assay
Microtubule-stimulated ATPase activities were measured as a func-
tion of microtubule concentration (0–10 lM) in assay buﬀer containing
kinesin (0.01–0.1 lM), 10 mM Tris–acetate, pH 7.5, 10 mM potassium
acetate, 2 mM magnesium acetate, 1 mM dithiothreitol (DTT), 1 mM
ATP, and 0.5 mM EGTA or 0.1 mM CaCl2 and 1 lg/ml calmodulin.
The Ca2+ sensitivity of the ATPase activity was measured at various
concentrations of CaCl2 (10 nM–1 mM) and calmodulin (0.37–
11.8 lM) in assay buﬀer containing 0.1 lM engineered kinesin, 5 lM
microtubules, 10 mM Tris–acetate, pH 7.0, 10 mM potassium acetate,
2 mM magnesium acetate, 0.5 mg/ml casein, 1 mM DTT, and 1 mM
ATP. The amount of inorganic phosphate released was determined
[19]. Each reaction was initiated by adding ATP, and terminated by
the addition of sodium dodecyl sulfate (SDS) at a ﬁnal concentration
of 6%. All assays were performed at 30 C.
2.4. Calmodulin binding assay
To evaluate the binding of calmodulin to engineered kinesin, we
used the BIACORE J system (BIACORE). Engineered kinesin was
ﬁxed to the gold surface of a BIACORE CM5 chip, and equilibrated
with assay buﬀer containing 10 mM HEPES, pH 8.0, 10 mM potas-
sium acetate, 2 mM magnesium acetate. Calmodulin (0.74–23.5 lM)
in buﬀer (10 mM HEPES, pH 8.0, 10 mM potassium acetate, 2 mM
magnesium acetate, 1 mM CaCl2) was applied to the chip. Binding
curves were measured at room temperature, and the dissociation con-
stant (Kd) was calculated.
2.5. Co-sedimentation assay
Kinesin (3 lM) and microtubules (10 lM) were mixed in a binding
reaction buﬀer (10 mM Tris–acetate, pH 7.5, 10 mM potassium ace-
tate, 2 mM magnesium acetate, 2 mM EGTA or 0.2 mM CaCl2,
with/without 0.2 mg/ml calmodulin, with/without 2 mM MgATP)
and incubated for 5 min at room temperature, followed by ultracentri-
fugation at 138000 · g for 1 h at 30 C. To quantify the amounts of
kinesin in the supernatant and precipitate, we performed SDS–PAGE
using 4–20% gradient gels and densitometric scanning of gels stained
with Coomassie Brilliant Blue.3. Results and discussion
We inserted the amino acid sequence of M13 into Loop 12
[20], one of the major microtubule binding regions of kinesin
(Fig. 1A). We predicted that Ca2+-calmodulin bound to the
M13 peptide in Loop 12 would interfere with interactions be-
tween kinesin and the microtubules, thus inhibiting motility(Fig. 1B). Engineered kinesin with the M13 peptide sequence
inserted into Loop 12 was truncated at residue 560, and fused
to a 6 · His tag at its C-terminus. The fusion protein was ex-
pressed in E. coli, and puriﬁed to homogeneity using Ni-NTA
agarose column chromatography. To conﬁrm that interactions
between calmodulin and the M13 peptide are functional in
engineered kinesin, we measured kinesin binding to calmodulin
using surface plasmon resonance. The dissociation constant
(Kd) in the presence of 1 mM Ca
2+ was estimated to be
1.42 lM (data not shown). The Kd of calmodulin binding to
the isolated M13 peptide is in the nM range [14], indicating that
insertion of the peptide sequence into kinesin has a negative ef-
fect on calmodulin binding. Nonetheless, aKd value of 1.42 lM
is suﬃciently low for the practical purposes envisaged.
The ATPase activity of engineered kinesin was measured in
the presence or absence of microtubules (Fig. 2A, Table 1). In
control experiments, the ATPase activity of wild-type kinesin
was signiﬁcantly enhanced by microtubules. Moreover, the
Ca2+-calmodulin complex had no apparent eﬀect on wild-type
activity. In contrast, the activity of engineered kinesin was sig-
niﬁcantly aﬀected by the Ca2+-calmodulin complex (Table 1).
In the absence of Ca2+-calmodulin, the activity of engineered
kinesin was stimulated by microtubules, but with a calculated
Vmax that was about 30% of the wild-type. However, in the
presence of Ca2+-calmodulin, the ATPase activity of engi-
neered kinesin incubated with 10 lM microtubules was re-
duced to about 1/300 of that in its absence (Fig. 2A). These
data indicate that the Ca2+-calmodulin complex inhibits the
ATPase activity of engineered kinesin. Interestingly, the basal
ATPase activity of engineered kinesin in the presence or ab-
sence of Ca2+-calmodulin was similar to that of wild-type (Ta-
ble 1). This ﬁnding suggests that insertion of the M13 peptide
into Loop 12, which mediates kinesin binding to calmodulin,
has no eﬀect on the intrinsic ATPase activity, even when cal-
modulin is bound. In view of the results obtained, we propose
that the Ca2+-calmodulin complex only inhibits the microtu-
bule-activated ATPase activity.
The Ca2+ sensitivity of the microtubule-stimulated ATPase
activity of engineered kinesin was measured in the presence
of 5 lM microtubules and various concentrations of Ca2+
and calmodulin (Fig. 2B). At pCa 8, the ATPase activity of
engineered kinesin was stimulated about 400-fold by microtu-
bules. The activity at pCa 8 was 12.5 ± 0.3 s1, and the basal
ATPase activity without microtubules but with Ca2+-calmodu-
lin was 0.03 ± 0.01 s1, despite the presence of approximately
110-fold molar excess of calmodulin. This activity was similar
to that observed in the presence of EGTA. The inhibitory ef-
fect was saturated at pCa 6 (IC50  100 nM). At intermediate
Ca2+ concentrations (pCa 6.5–8), the inhibitory eﬀect dimin-
ished with decreasing calmodulin concentrations. This is simi-
lar to the skeletal muscle myosin light chain kinase, which is
activated by Ca2+-bound calmodulin at pCa 6 7 [21]. This
steep dependence on Ca2+ concentration makes the M13 pep-
tide-modiﬁed kinesin suitable for all or none switching of the
microtubule movement in a nanoactuator system.
To utilize the engineered kinesin and microtubule system as
a nanoactuator, the motor activity must be able to be revers-
ibly turned on/oﬀ by a controllable trigger, such as Ca2+. As
shown in Fig. 3, this factor was examined using an in vitro
gliding motility assay in which wild-type or engineered kinesin
was attached to a glass surface, and the microtubule velocity
observed by tracing the movement of ﬂuorescently labeled
Fig. 1. Location of the inserted M13 peptide sequence in kinesin and schematic diagram of a kinesin-switching model. (A) Mutagenesis point (red
circle). The M13 peptide with a two-residue linker on each side was inserted between Thr273 and Tyr274 (green residues) of Loop 12 (salmon loop).
The crystal structure on the left is that of rat dimeric conventional kinesin (PDB ID:3KIN), and on the right is a magniﬁed view of one motor domain
of human conventional kinesin (PDB ID: 1MKJ), which corresponds to the boxed region of the dimeric kinesin on the left. (B) Model of the
mechanism by which engineered kinesin motility is reversibly regulated by Ca2+. The Ca2+-calmodulin complex switches oﬀ kinesin motility, and
EGTA switches on motility.
Fig. 2. ATPase activity of wild-type/engineered kinesin, the eﬀect of Ca2+-calmodulin, and Ca2+ sensitivity. (A) Microtubule-stimulated ATPase
activity was measured in the presence and absence of Ca2+-calmodulin. Results are representative of three to ﬁve independent preparations.
Engineered kinesin was completely switched oﬀ by the Ca2+-calmodulin complex. Filled and open symbols signify the ATPase activities in the
absence and presence of the Ca2+-calmodulin complex, respectively. (B) Ca2+ sensitivity of engineered kinesin. Microtubule-activated ATPase
activity of engineered kinesin was measured using 5lM microtubules and various Ca2+ and calmodulin concentrations. ATPase activities were
normalized against activity in assay buﬀer containing 0.5 mM EGTA. The horizontal and the vertical axes represent the negative logarithm of free
Ca2+ concentration (pCa) and ATPase activities of engineered kinesin, respectively. Diﬀerent concentrations for calmodulin are represented by
various colors (inset).
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Table 1
Basal ATPase activity and calculated Vmax and KMT values
Ca2+-calmodulin Wild-type kinesin Engineered kinesin
 +  +
Vmax (s
1) 25.4 ± 2.99 26.1 ± 3.36 7.94 ± 3.36 (0.02 ± 0.013)a
KMT (lM) 3.41 ± 1.96 3.49 ± 2.27 0.98 ± 0.37 ND
basal ATPase activity (s1) 0.02 ± 0.01 0.02 ± 0.01 0.01 ± 0.01 0.03 ± 0.01
Vmax and KMT were estimated from the microtubule-activated ATPase data by ﬁtting to the equation V = Vmax/(1 + KMT/[microtubules]). Basal
ATPase activities were measured under the conditions employed for microtubule-activated ATPase activity in the absence of microtubules. To
estimate Vmax and Kd, basal ATPase activity values were subtracted from microtubule-activated ATPase data. ATPase activity was measured from
three to ﬁve independent preparations of protein. Data are presented as means ± S.D.
aEngineered kinesin Vmax was measured in assay buﬀer containing 10 lM microtubules.
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ﬂushing the ﬂow cells alternatively with buﬀer containing
EGTA and buﬀer containing Ca2+-calmodulin. In the EGTA
assay buﬀer, microtubules moved smoothly and continuously
over the engineered kinesin-coated surface, but with a velocity
about 1/8 that of the wild-type counterpart. Upon replacing
the buﬀer with Ca2+-calmodulin containing buﬀer, microtu-
bule movement terminated within 10 s. Subsequent chelation
of Ca2+ by exchanging the assay buﬀer with that containing
EGTA restored movement at the original velocity within
20 s. This movement of microtubules regulated by Ca2+ was
reproduced in another cycle of buﬀer exchange. In contrast,
microtubule movement driven by wild-type kinesin was not
signiﬁcantly aﬀected by buﬀer exchange. Some microtubules
detached from the surfaces coated with engineered kinesin dur-
ing exposure to the Ca2+-calmodulin containing buﬀer, and
were washed away during the buﬀer exchange. This ﬁnding is
consistent with the theory that binding of calmodulin to engi-
neered kinesin reduces its aﬃnity for microtubules, since the
M13 peptide sequence is inserted into Loop 12, a microtu-
bule-binding region.Fig. 3. Reversibility of the chemical switch. The panels labeled ‘‘EGTA’’ an
and Ca2+-calmodulin containing assay buﬀer, respectively. We exchanged th
measured. At least 12 ﬁlaments were measured in each case. Error bars indiTo determine the extent of interference of calmodulin in
interactions between engineered kinesin and microtubules, we
performed a co-sedimentation assay to assess binding aﬃnity
(Fig. 4). About 90% of wild-type kinesin co-pelleted with
microtubules, both in the presence and absence of ATP, and
the Ca2+-calmodulin complex showed essentially no inhibitory
eﬀect on this interaction. Similarly, in the absence of Ca2+-cal-
modulin, approximately 90% of the engineered kinesin bound
to microtubules in a manner similar to that of the wild-type.
These data suggest that insertion of the M13 peptide sequence
into Loop 12 has no major eﬀect on microtubule binding. How-
ever, only 60% of the engineered kinesin co-pelleted with micro-
tubules in the presence of Ca2+-calmodulin, suggesting that the
complex partially blocks binding to microtubules. This result is
qualitatively consistent with ﬁndings of the gliding assay.
Kinesin-like calmodulin-binding protein (KCBP), plant-spe-
ciﬁc kinesin [15], is a minus-end directed motor whose interac-
tion with calmodulin via its calmodulin-binding domain
(CBD) inhibits its microtubule binding and microtubule-acti-
vated ATPase activities. Reddy and Reddy fused the CBD of
KCBP to the N- and C-terminus of NCD and to the C-termi-d ‘‘Ca2+-CaM’’ depict gliding motility assays in the EGTA-containing
e assay buﬀer four times, and the velocities under each condition were
cate standard deviation.
Fig. 4. Aﬃnity of kinesin for microtubules. Co-sedimentation assays
were performed after incubation of kinesin with microtubules. Total
amounts of kinesin in the supernatant (S) and pellet (P) were
normalized and set to 100% in each co-sedimentation condition (Error
bars, standard deviation). The graph depicts the amounts of kinesin
that co-pelleted with microtubules. Filled and open circles indicate
engineered and wild-type kinesin, respectively. Representative SDS–
PAGE gel images are shown above the graph.
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showed that the interaction of these chimeras, as well as that
of KCBP, with microtubules in the presence of AMP-PNP
was inhibited by Ca2+-calmodulin, and that this was accompa-
nied by a loss of approximately 90% of microtubule-activated
ATPase activity. Recently, the X-ray crystal structure of
KCBP was solved [22]. The crystal structure showed that the
CBD of KCBP is near Loop 8, another major microtubule-
binding site. It was thus suggested that steric hindrance due
to calmodulin binding leads to weaker aﬃnity of kinesin for
microtubules. The inhibitory mechanism of our engineered
Ca2+-sensitive kinesin may be similar, although the extent of
inhibition of microtubule-activated ATPase activity is signiﬁ-
cantly higher (1/300-fold repression, compared with 1/10-fold
in KCBP [23] and CBD fusion motors [16]). Moreover, 60%
of our engineered kinesin could bind to microtubules even in
the presence of ATP and Ca2+-calmodulin. The issue whether
these diﬀerences are due to the position of the inserted peptides
(inside Loop 12 versus close to Loop 8) or the sequence in-
serted (M13 versus CBD) remains to be elucidated.
It is, however, intriguing that 60% of the engineered kinesin
binds to microtubules in the presence of the Ca2+-calmodulin
complex (Fig. 4), although the microtubule-activated ATPase
activity and motility are almost completely inhibited
(Fig. 2A, Table 1, Fig. 3). If simple steric hindrance due to
the Ca2+-calmodulin complex interferes with microtubule
binding and results in the oﬀ-state, 60% of the kinesin proteinshould remain activated. We thus propose that binding
of calmodulin to Loop 12 additionally interferes with the
microtubule-stimulated conformational changes in the motor
domain and activation pathway. Further studies on our
Ca2+-sensitive engineered kinesin are required to clarify its
motor mechanism.
We have succeeded in installing a Ca2+ dependent reversible
switch into kinesin to regulate motility. Although Ca2+ con-
centration was controlled by exchanging buﬀer in this study,
a combination of this engineered kinesin with technology to
control Ca2+ in ﬂow cells by external signals, such as an elec-
tric ﬁeld, should enable external and local control of kinesin
motility in the future. These developments, in addition to oth-
ers, including the recent achievements of directional control of
biomotors [7,18,24,25] and dielectric thin ﬁlm technology are
the key tools required to generate nanoactuator systems with
electric controls.
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